Rheumatoid arthritis (RA) is a disease in which your immune system attacks your own joints, causing chronic inflammation that gradually destroys cartilage and bone. But it doesn’t stop at the joints. RA is a systemic disease, meaning it can affect your lungs, heart, blood vessels, and bones throughout your body. The damage it causes depends largely on how early it’s caught and how well the inflammation is controlled.
How RA Damages Your Joints
In a healthy joint, the synovium (the thin tissue lining the inside of the joint capsule) is only one to three cells thick. Its job is to produce fluid that lubricates the joint. In RA, the immune system floods the synovium with inflammatory cells, causing it to swell to eight to ten cells thick. New blood vessels grow into the area, feeding the expanding tissue and bringing even more immune cells.
This thickened, aggressive tissue is called pannus. It behaves almost like a slow-growing tumor, creeping over and into the cartilage and bone at the edges of the joint. Unlike a tumor, it doesn’t spread to distant parts of the body, but within the joint itself it is relentless. The pannus releases enzymes that dissolve cartilage and activates bone-destroying cells called osteoclasts, which chew away at the underlying bone. Over months and years, this process narrows the joint space, creates visible erosions on X-rays, and eventually destabilizes the joint entirely.
The chemical signals driving this process are inflammatory molecules, primarily TNF-alpha, interleukin-1, and interleukin-6. These molecules are found in high concentrations in the joint fluid of people with RA, and they do double duty: they amplify the immune attack locally while also sending inflammatory signals throughout the bloodstream, which is why RA affects organs far from the joints.
What It Feels Like Day to Day
The hallmark symptom is prolonged morning stiffness. Unlike the brief stiffness you might feel from sleeping in an awkward position, RA stiffness typically lasts at least 30 minutes and often over an hour. It tends to affect joints symmetrically: both wrists, both sets of knuckles, both knees. The joints feel warm, swollen, and tender, and the stiffness gradually loosens with movement over the course of the morning.
Fatigue is the other defining feature, and many people with RA say it’s harder to cope with than the pain. It’s not ordinary tiredness. The constant low-grade inflammation demands energy from your body the way fighting an infection does, leaving you drained even after a full night’s sleep. Flares, periods when the disease becomes more active, can bring fever, deeper exhaustion, and sharp increases in joint pain that last days to weeks before settling down.
Finger and Hand Deformities
The small joints of the hands are often hit first and hardest. Inside each finger, a complex network of tendons and muscles acts like a system of levers and pulleys, balancing the forces that bend and straighten each joint. When RA weakens or damages any part of this system, the balance tips and the finger locks into an abnormal position.
Two classic patterns emerge. In swan-neck deformity, the middle joint of the finger bends backward (hyperextends) while the fingertip curls forward. In boutonniere deformity, the opposite happens: the middle joint buckles forward while the tip bends back. Both result from tendon damage shifting the mechanical forces across the finger’s joints. These deformities develop gradually and, once established, can make gripping, pinching, and fine motor tasks difficult or impossible without surgical correction.
Effects on the Lungs
Lung involvement is more common than many people realize. Roughly 30% of RA patients show signs of interstitial lung disease (scarring of the lung tissue) on high-resolution CT scans, even when they have no breathing symptoms. The scarring thickens the walls of the tiny air sacs where oxygen enters the blood, making gas exchange less efficient. Over time, this can cause a persistent dry cough and progressive shortness of breath, particularly with exertion.
RA can also affect the airways and the lining around the lungs. About 30% of patients show bronchiectasis, a widening and scarring of the airways, on imaging. Pleural effusions (fluid buildup around the lungs) show up in autopsy studies in up to 70% of RA patients, though only 3 to 5% ever develop symptoms from them. The airways of the upper throat can be involved too: RA can cause nodules on the vocal cords or inflammation of the small joint that moves them, leading to hoarseness or voice changes.
Lung disease is the second leading cause of death in RA, after heart disease.
Effects on the Heart and Blood Vessels
The same inflammatory molecules that destroy joints also accelerate atherosclerosis, the buildup of plaque inside arteries. People with RA have a significantly higher risk of heart attack and stroke compared to the general population, and this risk exists even in people who don’t have traditional risk factors like high cholesterol or smoking. Chronic inflammation damages the inner lining of blood vessels, making them stiffer and more prone to plaque rupture.
RA also increases the risk of blood clots. Patients face higher rates of both deep vein thrombosis and pulmonary embolism compared to people without the disease. Pulmonary hypertension (high blood pressure in the arteries of the lungs) can develop as well, usually alongside lung scarring but occasionally on its own.
Bone Loss Beyond the Joints
RA doesn’t just erode bone at the joint surface. It causes systemic bone loss throughout the skeleton, raising your risk of osteoporosis and fractures. This happens through several overlapping mechanisms. The same antibodies involved in RA (called ACPAs) can directly stimulate the bone-destroying osteoclast cells far from any inflamed joint. Chronic inflammation itself suppresses new bone formation. Many RA patients take corticosteroids, which further weaken bones. And the pain and fatigue of the disease reduce physical activity, which is one of the strongest stimuli for maintaining bone density.
The result is that RA is considered an independent risk factor for fractures, particularly of the hip and spine, even after accounting for medication use and activity level.
How RA Is Identified
Two blood tests help confirm the diagnosis. Rheumatoid factor (RF) is the older test, with a sensitivity between 55% and 90%, meaning it catches most but not all cases. Its weakness is specificity: a positive RF can show up in other conditions, and its positive predictive value is only about 30% when used alone. The anti-CCP antibody test is more precise. It has a sensitivity of about 68% (it misses roughly a third of RA cases) but a specificity above 95%, meaning a positive result is almost certainly RA. Together, the two tests give a much clearer picture than either one alone.
Imaging and clinical examination fill in the rest. Symmetric joint swelling in the hands and feet, prolonged morning stiffness, and elevated inflammatory markers in the blood all point toward the diagnosis. The newer classification criteria place heavy emphasis on catching RA early, before erosions show up on X-rays, because the window for preventing permanent damage is narrow.
How Treatment Changes the Outlook
Without treatment, RA is associated with a mortality risk roughly 40 to 57% higher than the general population. A national study in Lithuania found the risk of death was 41% higher in RA patients, and a 20-year Australian study found the gap widened over time, with mortality reaching 49% higher after two decades. The leading causes of death are cardiovascular disease, lung disease, and cancer.
Modern treatment has changed these numbers substantially, though not eliminated the gap. The strategy is to suppress inflammation as quickly and completely as possible using disease-modifying drugs. Biologic therapies, which block specific inflammatory molecules like TNF-alpha or interleukin-6, can halt joint erosion and reduce systemic inflammation. However, full pain remission remains difficult to achieve. In studies of biologic therapy, only about one-quarter to one-third of patients reach a state where their pain is essentially gone, highlighting that even with effective treatment, many people continue to manage residual symptoms.
Early, aggressive treatment within the first months of symptoms offers the best chance of preventing joint damage and protecting organs. The disease doesn’t burn out on its own. Left unchecked, it progressively destroys joints, weakens bones, scars lungs, and damages blood vessels, making RA far more than “just arthritis.”